Literature DB >> 15336807

Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy.

Claudio Passino1, Ferdinando Franzoni, Alessandra Gabutti, Roberta Poletti, Fabio Galetta, Michele Emdin.   

Abstract

BACKGROUND: An increased risk for life-threatening arrhythmias and sudden death has been observed in hypertensive patients, associated with either left ventricular hypertrophy (LVH) or prolonged QT interval. To investigate the influence of autonomic imbalance and LVH on QT interval in hypertensive patients, we compared two different models of LVH: hypertension and endurance physical training.
METHODS: Forty-seven untreated subjects affected by essential hypertension and 35 endurance runners, with a similar degree of LVH, were enrolled into the study. All subjects underwent 24-h ambulatory ECG recording and morning blood sampling for catecholamines. Heart rate variability was evaluated by spectral analysis and a computerized algorithm was used to measure the QT interval; QTc was then computed by the Bazett's formula. Left ventricular mass index (LVMI) was assessed by echocardiogram.
RESULTS: No difference in LVMI was found between hypertensive patients and athletes. Athletes showed lower heart rate (64 +/- 1 vs. 75 +/- 1 bpm, p<0.001, mean +/- S.E.M.) and shorter QTc (401 +/- 3 vs. 434 +/- 4 ms, p<0.001) than hypertensive patients throughout the 24-h period. Athletes showed a higher vagal drive compared to hypertensive patients as suggested by bradycardia and higher values of vagal indices, which negatively correlated with QTc. Plasma norepinephrine was significantly lower in athletes than in hypertensive patients (p<0.05) and positively correlated with QTc.
CONCLUSION: Despite similar degrees of LVH, hypertensive patients show QTc lengthening, as compared to athletes. Heart rate variability and plasma norepinephrine levels suggest sympathetic predominance in hypertensive patients, which could contribute to abnormal ventricular repolarization, thus identifying patients with an increased arrhythmic risk. Copyright 2003 Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15336807     DOI: 10.1016/j.ijcard.2003.07.029

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

2.  A Novel Electrocardiographic T-Wave Measurement (Tp-Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First-Line Electrocardiographic Evaluation.

Authors:  Andrea Ferrucci; Flaminia Canichella; Allegra Battistoni; Francesca Palano; Pietro Francia; Giuseppino Massimo Ciavarella; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-13       Impact factor: 3.738

3.  QT Interval Variability Index and QT Interval Duration in Different Sleep Stages: Analysis of Polysomnographic Recordings in Nonapneic Male Patients.

Authors:  Moonika Viigimae; Deniss Karai; Peeter Pirn; Kristjan Pilt; Kalju Meigas; Jyri Kaik
Journal:  Biomed Res Int       Date:  2015-11-29       Impact factor: 3.411

4.  ECG Multilead QT Interval Estimation Using Support Vector Machines.

Authors:  Jhosmary Cuadros; Nelson Dugarte; Sara Wong; Pablo Vanegas; Villie Morocho; Rubén Medina
Journal:  J Healthc Eng       Date:  2019-04-15       Impact factor: 2.682

5.  Influence of the left ventricular types on QT intervals in hypertensive patients.

Authors:  Juraj Kunisek; Luka Zaputovic; Zlatko Cubranic; Leon Kunisek; Marta Zuvic Butorac; Ksenija Lukin-Eskinja; Rade Karlavaris
Journal:  Anatol J Cardiol       Date:  2014-04-02       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.